Grenitab MD Tablet

Grenitab MD Tablet belongs to the class of ‘anti-emetic’ drugs, primarily used to treat nausea and vomiting caused by medical treatments, such as chemotherapy or radiation treatment for cancer. Nausea is defined as stomach discomfort and the sensation of an urge to vomit. Vomiting is the forcible, voluntary, or involuntary emptying of the contents of the stomach through the mouth.

Grenitab MD Tablet contains an anti-emetic (eases vomiting symptoms) medicine, 'Granisetron', that belongs to the serotonin receptor antagonists or serotonin blockers class. It works by blocking the activity of serotonin (chemical messenger) in the brain that triggers nausea and vomiting during cancer treatment (chemotherapy or radiation therapy) or after surgery.

Your doctor will decide the dose and duration based on the severity of your medical condition. Common side effects of Grenitab MD Tablet include diarrhoea, constipation, stomach pain, weakness, headache, fever, dizziness, drowsiness, trouble sleeping, and anxiety. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor.

If you use other prescription or non-prescription medicines, inform your doctor before using Grenitab MD Tablet. Let your doctor know if you have any liver, kidney, or heart diseases, stomach/intestinal problems, allergic reactions, or low potassium and magnesium levels in the blood before starting Grenitab MD Tablet. Grenitab MD Tablet may make you dizzy or drowsy, hence avoid driving if you are not mentally alert. Consult your doctor before taking Grenitab MD Tablet if you are pregnant, planning for pregnancy, or breastfeeding. Avoid consuming alcohol along with Grenitab MD Tablet as it could lead to increased drowsiness.

• Grenitab MD Tablet can be taken with or without food, or as your doctor advises.
• Follow your doctor's instructions on the dosage and timing of this medication.
• Swallow Grenitab MD Tablet as a whole with a glass of water.
• Do not crush, break, or chew it.

Grenitab MD Tablet contains an anti-emetic drug, 'Granisetron', that treats nausea and vomiting caused by cancer treatment (chemotherapy or radiation therapy) or after surgery, etc. Granisetron belongs to the class of 5-HT3 receptor antagonists (also called serotonin receptor antagonists or serotonin blockers). When the cells lining the gastrointestinal tract are damaged by chemotherapy or radiation therapy, they release a natural substance called serotonin (5HT3, 5-hydroxytryptamine). This serotonin binds to serotonin receptors on nerves that induce nausea and vomiting. Grenitab MD Tablet works by blocking the brain's serotonin activity and preventing post-operative nausea and vomiting.

Grenitab MD Tablet may cause serotonin syndrome/toxicity when used with other drugs like ecstasy (MDMA) and antidepressants. Hence it is suggested to seek medical advice if you are using any prescription or non-prescription medicines. Inform your doctor if you have a history of stomach/intestinal problems like stomach ache, wind, feeling or being sick, and difficulty passing stools, heart problems, electrolyte imbalance (potassium, sodium or calcium), and liver or kidney diseases before starting Grenitab MD Tablet. Please consult your doctor if you are pregnant or breastfeeding if the doctor has advised you Grenitab MD Tablet. Grenitab MD Tablet may make you feel dizzy, so drive only if you are alert. Avoid consuming alcohol as it could lead to increased dizziness. Grenitab MD Tablet is not recommended in children below two years of age.